A. Desplaces

发表

Quantitative morphological aspects of granulocytic differentiation induced in HL-60 cells by dimethylsulfoxide and retinoic acid.

J. Dufer, D. Biakou, P. Joly, 1989, Leukemia research.

Quantitative morphological analysis of adriamycin-resistant human K562 leukemic cells.

J. Dufer, A. Desplaces, P. Jeannesson, 1989, Cytometry.

Flow cytometric analysis of DNA content and keratins by using CK7, CK8, CK18, CK19, and KL1 monoclonal antibodies in benign and malignant human breast tumors.

F. Spyratos, A. Desplaces, V. Le Doussal, 1990, Cytometry.

Effect of a pulsed magnetic field on tumoral C3H/Bi female mice.

A. Desplaces, R. Morin, A. Bellossi, 1988, Cancer biochemistry biophysics.

The effects of silymarin on experimental phalloidine poisoning.

A. Desplaces, J. Choppin, W. Trost, 1975, Arzneimittel-Forschung.

The effects of silybin on experimental phalloidine poisoning.

A. Desplaces, J. Choppin, 1978, Arzneimittel-Forschung.

Thymus-derived proliferating lymphocytes in chronic lymphocytic leukaemia.

A. Desplaces, J. Brouet, R. Saracino, 1973, Lancet.

Studies on the susceptibility to NK-mediated lysis and the simultaneous expression of various surface molecules in anthracyclin-treated K562 cells and in four K562 cell clones.

J. Dufer, P. Joly, H. Benoist, 1992, Immunology letters.

Relationship between cathepsin D, urokinase, and plasminogen activator inhibitors in malignant vs benign breast tumours.

A. Desplaces, K. Hacène, P. Martin, 1991, British Journal of Cancer.

Cytokeratin analysis of breast and leukemia tumor cell lines by flow cytometry

F. Spyratos, E. Phillips, A. Desplaces, 1989, Biology of the cell.

Nuclear DNA content and chromatin texture in multidrug‐resistant human leukemic cell lines

J. Dufer, P. Joly, A. Desplaces, 1995, International Journal of Cancer.

Dipeptidyl-amino-peptidase IV activity in stored buffy coat smears from human blood.

J. Dufer, A. Desplaces, A. Leroy, 1986, Stain technology.

Prognostic Value of Deoxyribonucleic Acid (DNA) and Ribonucleic Acid (RNA) Content of Human Breast Carcinomas: Correlation with Clinical and Histologic Features and Hormone Receptors

R. Lidereau, F. Spyratos, A. Desplaces, 1986 .

[Study of the thyroid function of the germ-free rat].

A. Desplaces, D. Zagury, E. Sacquet, 1963, Comptes rendus hebdomadaires des seances de l'Academie des sciences.

Characterization of Acidic Vesicles in Multidrug-resistant and Sensitive Cancer Cells by Acridine Orange Staining and Confocal Microspectrofluorometry

M. Manfait, J. Millot, A. Desplaces, 1997, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

Human autologous rosettes. II. Further characterization: markers and functions.

J. Dufer, A. Desplaces, D. Zagury, 1981, Cellular immunology.

Tissue Plasminogen Activator in the Cytosol of Breast Tumors: Technical Aspects and Correlations with Commonly Used Prognostic Factors

F. Spyratos, A. Desplaces, K. Hacène, 1985 .

The Lancet: saturday 11 November 1989

T. Maudelonde, F. Spyratos, H. Rochefort, 1989 .

CATHEPSIN D: AN INDEPENDENT PROGNOSTIC FACTOR FOR METASTASIS OF BREAST CANCER

T. Maudelonde, F. Spyratos, H. Rochefort, 1989, The Lancet.

Adriamycin induced resistance of sensitive K 562 cells to natural killer lymphocyte attack

H. Benoist, A. Desplaces, J. Jardillier, 2004, Cancer Immunology, Immunotherapy.

Comparative effects of fagaronine, Adriamycin and aclacinomycin on K562 cell sensitivity to natural-killer-mediated lysis

J. Dufer, P. Joly, H. Benoist, 1989, Cancer Immunology, Immunotherapy.

Association of adriamycin‐induced resistance to NK‐mediated lysis with sialic acid level and immunological reactivity of transferrin receptors and glycophorin A

P. Joly, H. Benoist, Y. Carpentier, 1988, International journal of cancer.

Modification of the Regulation of Interleukin 2 (IL2) in Human Breast Cancer

R. Lidereau, D. Fradelizi, A. Desplaces, 1985 .

Differential effect of the serine protease inhibitor phenyl methyl sulfonyl fluoride on cytochemically detectable esterases in human leucocytes and platelets.

J. Dufer, A. Desplaces, C. Trentesaux, 2009, Scandinavian journal of haematology.

[Cytochemical study of rat leukocytes treated with methoxy-9 ellipticine].

J. Dufer, A. Desplaces, M. Aurousseau, 1973, Annales Pharmaceutiques Françaises.

Flow cytometric study of DNA distribution in cytopunctures of benign and malignant breast lesions.

F. Spyratos, A. Desplaces, M. Brunet, 1987, Analytical and quantitative cytology and histology.

Immunological study of axillary lymphnodes in patients with breast cancer.

A. Desplaces, P. Guerin, A. Gentile, 1977, European journal of cancer.

Effect of a 9 mT pulsed magnetic field on C3H/Bi female mice with mammary carcinoma. A comparison between the 12 Hz and the 460 Hz frequencies.

A. Desplaces, A. Bellossi, 1991, In vivo.

Competitive prognostic value of clinicopathologic and bioimmunologic factors in primary breast cancer

R. Lidereau, A. Desplaces, K. Hacène, 1986, Cancer.

Tissue glycolytic enzymes in primary breast cancer patients receiving adjuvant chemotherapy.

R. Lidereau, F. Spyratos, A. Desplaces, 1986, European journal of cancer & clinical oncology.

J. Dufer, D. Biakou, H. Benoist, 1987, Mechanisms of Ageing and Development.